Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-15

FDA Approved: FEXINIDAZOLE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for fexinidazole from Sanofi-Aventis U.S. LLC, updating the product label (and indications) for the treatment of human A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

SUPPL AP for FEXINIDAZOLE (FEXINIDAZOLE)